Yield-protecting options strategies are positioned in such a way that they leave room for MO stock to potentially explore the ...

If you’re searching for a sensible stock that delivers both value and income, Altria Group ($MO) stands out. That’s ...

Altria Group, Inc.’s (MO) nicotine pouch business, operated through Helix Innovations, is becoming a growing driver of the ...

According to Benzinga Pro, Altria Group Inc's peer group average for short interest as a percentage of float is 3.54%, which ...

The Food and Drug Administration on Friday issued marketing granted orders to six On Plus nicotine pouch products. They are the first authorizations under a pilot program launched in September to ...

Altria has underperformed the S&P 500 in recent years. The stock remains a dividend powerhouse with a yield above 7%. Its future is tied to next-gen products like Njoy ...

The FTC began its investigation before Altria purchased a 35% stake in Juul, according to The Wall Street Journal.

The U.S. Food and Drug Administration (FDA) has authorized the marketing of six on! PLUS nicotine pouch products owned by ...

Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior ...

Altria stock (NYSE: MO) currently trades at $45 per share, around 20% below its level of $57 on May 7, 2022 (pre-inflation shock high), and it seems like it has the potential for sizable gains. Altria ...

Altria bought a 45% stake in Cronos Group for $1.8 billion in 2021. The marijuana market has collapsed due to regulatory snafus in Canada and slow-walking legalization in the U.S. Altria has better ...

Altria (NYSE: MO) saw its stock price plummet by almost 40% over the last 3 years, from $74 in February 2017 to about $45 in February 2020. This drop was primarily driven by a complete washout of ...